Evidence map›Paper›PMID 32732999›Full record

ArticleNature communications2020

Identification of relevant genetic alterations in cancer using topological data analysis.

Raúl Rabadán, Yamina Mohamedi, Udi Rubin, Tim Chu, Adam N Alghalith, Oliver Elliott, Luis Arnés, Santiago Cal, Álvaro J Obaya, Arnold J Levine and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Assessment of Methylation in SelectedInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Advancing Precision Medicine: Algebraic Topology and Differential Geometry in Radiology and Computational Pathology.Laboratory investigation; a journal of technical methods and pathology · 2024
    Review
  6. Article
  7. Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. The topology of data: opportunities for cancer research.Bioinformatics (Oxford, England) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Raúl RabadánDepartments of Systems Biology and Biomedical Informatics, Columbia University, 1130 St. Nicholas Ave., New York, NY, 10032, USA. rr2579@cumc.columbia.edu.ORCID http://orcid.org/0000-0001-7946-9255
Yamina MohamediDepartamento de Bioquimica y Biologia Molecular, Universidad de Oviedo, Oviedo, Asturias, Spain.
Udi RubinDepartments of Systems Biology and Biomedical Informatics, Columbia University, 1130 St. Nicholas Ave., New York, NY, 10032, USA.
Tim ChuDepartments of Systems Biology and Biomedical Informatics, Columbia University, 1130 St. Nicholas Ave., New York, NY, 10032, USA.
Adam N AlghalithDepartment of Genetics and Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA.ORCID http://orcid.org/0000-0002-7258-1567
Oliver ElliottDepartments of Systems Biology and Biomedical Informatics, Columbia University, 1130 St. Nicholas Ave., New York, NY, 10032, USA.
Luis ArnésDepartments of Systems Biology and Biomedical Informatics, Columbia University, 1130 St. Nicholas Ave., New York, NY, 10032, USA.
Santiago CalDepartamento de Bioquimica y Biologia Molecular, Universidad de Oviedo, Oviedo, Asturias, Spain.
Álvaro J ObayaIUOPA, Instituto Universitario de Oncologia, Oviedo, Asturias, Spain.
Arnold J LevineThe Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, 08540, USA. alevine@ias.edu.
Pablo G CámaraDepartment of Genetics and Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA, 19104, USA. pcamara@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0001-6822-3604
Columbia University · USUniversidad de Oviedo · ESUniversity of Pennsylvania · USColumbia University Irving Medical Center · USInstitute for Advanced Study · USMemorial Sloan Kettering Cancer Center · US

Funding

Topology of Cancer Evolution and HeterogeneityU54CA193313 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2015 to 2020
$10.4M
NCI NIH HHS U54 CA193313
6 · The paper itself

Abstract

Large-scale cancer genomic studies enable the systematic identification of mutations that lead to the genesis and progression of tumors, uncovering the underlying molecular mechanisms and potential therapies. While some such mutations are recurrently found in many tumors, many others exist solely within a few samples, precluding detection by conventional recurrence-based statistical approaches. Integrated analysis of somatic mutations and RNA expression data across 12 tumor types reveals that mutations of cancer genes are usually accompanied by substantial changes in expression. We use topological data analysis to leverage this observation and uncover 38 elusive candidate cancer-associated genes, including inactivating mutations of the metalloproteinase ADAMTS12 in lung adenocarcinoma. We show that ADAMTS12

Indexed as

ADAMTS ProteinsAdenocarcinoma of LungAnimalsCell Line, TumorComputational BiologyData AnalysisGenetic Predisposition to DiseaseLung NeoplasmsMiceMice, Inbred C57BLMice, KnockoutMutationNeoplasm Recurrence, LocalOncogenesAdamts12 protein, mouseADAMTS Proteins

Identifiers

PMID32732999
PMCPMC7393176
OpenAlexW3045861332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.